Estimaciones de analistas de Wall Street para Edesa Biotech, Inc. (EDSA): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-12-11 | $-0.58 | ||
| 2026-08-13 | $-0.60 | $-0.43 | -37.9% |
| 2026-05-14 | $-0.49 | $-0.24 | -104.2% |
| 2026-02-13 | $-0.28 | $-0.28 | +0.0% |
| 2025-12-12 | $-0.32 | $-0.27 | -18.5% |
| 2025-08-08 | $-0.25 | $-0.26 | +3.8% |
| 2025-05-14 | $-0.30 | $-0.30 | +0.0% |
| 2025-02-14 | $-0.48 | $-0.31 | -54.8% |
Ratios de valoración
| Precio / Valor contable | 3.96 |
| EV / EBITDA | -2.46 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.3M | $228287 | $211849 | $410870 | $328801 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $1.1M | $534453 | $445320 | $101286 | $17601 | $118788 | 0 | 0 | 0 | $119273 |
| Beneficio Bruto | $143861 | -$306166 | -$233471 | $309584 | $311200 | -$118788 | 0 | 0 | 0 | -$119273 |
| I+D | $1.7M | $2.0M | $2.1M | $1.1M | $3.3M | $17.9M | $13.3M | $4.8M | $2.9M | $3.7M |
| Generales y Administrativos | $3.3M | $2.9M | $2.8M | $2.0M | $3.4M | $5.7M | $5.0M | $4.4M | $4.1M | $4.2M |
| Gastos Operativos | $5.1M | $4.9M | $4.8M | $3.1M | $6.7M | $23.7M | $18.4M | $9.2M | $7.0M | $7.8M |
| Beneficio Operativo | -$4.9M | -$5.2M | -$5.1M | -$2.8M | -$6.4M | -$23.7M | -$18.4M | -$9.2M | -$7.0M | -$7.9M |
| EBITDA | -$4.9M | -$4.9M | -$4.8M | -$2.8M | -$6.3M | -$13.2M | -$17.5M | -$8.5M | -$6.1M | -$7.1M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$5.0M | -$5.0M | -$5.0M | -$2.8M | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | -$7.2M |
| Impuestos | $7200 | $800 | $800 | -$55404 | $800 | $800 | $800 | $800 | $800 | $800 |
| Beneficio Neto | -$5.0M | -$5.0M | -$5.0M | -$2.7M | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | -$7.2M |
| BPA | $-23.92 | $-36.78 | $-3.32 | $-4.79 | $-5.18 | $-7.73 | $-8.37 | $-2.93 | $-1.93 | $-1.27 |
| BPA Diluido | $-23.92 | $-36.78 | $-3.32 | $-4.79 | $-5.18 | $-7.73 | $-8.37 | $-2.93 | $-1.93 | $-1.27 |
| Acciones en Circulación (Diluidas) | $210150 | $23810 | $462843 | $655318 | $1.2M | $1.7M | $2.1M | $2.9M | $3.2M | $5.7M |
Precio
| Precio | $3.87 |
| Capitalización | $37M |
| Bolsa | NASDAQ |
| País | CA |
Empresas relacionadas: BRTX · COCP · DWTX · ERNA · EVGN · IMNN · IMRN
Explorar sector: Healthcare · Biotechnology
Más secciones de EDSA: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones